Cancer treatment has evolved beyond traditional chemotherapy and radiation. One of the most important advancements in oncology is targeted therapy, which is a precision-based treatment designed to attack specific cancer cell features without harming as many healthy cells.
Unlike chemotherapy, which affects rapidly dividing cells broadly, targeted therapy focuses on molecular changes that help cancer grow and spread. This personalized approach has improved outcomes in several cancer types.
This article explains how targeted therapy works, its benefits, possible side effects, and which patients may be eligible.
What Is Targeted Therapy in Cancer Care?
Targeted therapy is a type of cancer treatment that blocks specific proteins, genes, or other molecules involved in cancer growth and survival.
Cancer cells generally have genetic mutations or abnormal proteins that allow them to grow uncontrollably. Targeted therapy is designed to interfere with these specific abnormalities.
This approach may:
- Stop cancer cells from dividing
- Block tumor blood supply
- Trigger cancer cell death
- Deliver toxic substances directly to cancer cells
Because it acts on specific molecular targets, targeted therapy is sometimes referred to as precision medicine.
How Targeted Therapy Works at the Molecular Level
To understand targeted therapy, it is important to know that cancer cells often differ from normal cells in specific genetic or protein markers.
1. Blocking Growth Signals
Some cancer cells depend on growth factor receptors on their surface. Targeted drugs can block these receptors, preventing signals that promote tumor growth.
2. Inhibiting Angiogenesis
Tumors require a blood supply to grow. Certain targeted therapies block angiogenesis, which is the formation of new blood vessels, cutting off nutrients to the tumor.
3. Targeting Genetic Mutations
Some cancers carry specific genetic mutations, such as HER2, EGFR, or BRAF. Targeted therapy can specifically attack cells with these mutations while sparing normal cells.
4. Delivering Targeted Toxins
Monoclonal antibodies can attach to cancer cells and deliver chemotherapy drugs or radioactive substances directly to the tumor.
Types of Targeted Therapy
Targeted therapy is generally categorized into two main groups:
Small Molecule Drugs
These drugs enter cells and block internal signaling pathways responsible for cancer growth.
Monoclonal Antibodies
These laboratory-produced molecules attach to specific targets on cancer cells and interfere with their function.
Both forms are widely used depending on the cancer type and molecular profile.
Which Cancers Are Treated with Targeted Therapy?
Targeted therapy is used in various cancers, including:
- Breast cancer (HER2-positive)
- Lung cancer (EGFR or ALK mutations)
- Colorectal cancer
- Melanoma
- Leukemia and lymphoma
- Kidney cancer
The success of treatment depends on identifying specific tumor markers through biomarker testing.
In Delhi, individuals exploring targeted therapy in Delhi usually undergo molecular profiling and genetic testing to determine whether their cancer contains treatable mutations before beginning treatment.
Benefits of Targeted Therapy
Targeted therapy offers several advantages compared to conventional chemotherapy, including:
Greater Precision
Because the treatment focuses on specific cancer cell features, it may reduce damage to healthy tissues.
Personalized Treatment Plans
Biomarker testing allows doctors to tailor treatment based on individual tumor characteristics.
Improved Tolerability in Some Patients
While side effects still occur, targeted therapy may cause fewer systemic symptoms compared to traditional chemotherapy.
Combination Potential
Targeted therapy may be combined with chemotherapy, immunotherapy, or radiation to improve treatment outcomes.
Who Is Eligible for Targeted Therapy?
Eligibility depends on several factors, such as:
Tumor Biomarker Presence
The tumor must contain specific genetic mutations or protein markers that the drug can target. Without these markers, targeted therapy may not be effective.
Cancer Type and Stage
Certain cancers are more responsive to targeted therapy, particularly when specific mutations are present.
Overall Health Condition
Patients must have adequate organ function and overall health to tolerate treatment safely.
Doctors usually perform a biopsy and molecular testing before recommending targeted therapy.
Side Effects of Targeted Therapy
Although targeted therapy is designed to minimize harm to normal cells, side effects can still occur.
Common side effects include:
- Skin rash
- Diarrhea
- Fatigue
- High blood pressure
- Liver function changes
Some drugs may cause heart-related effects or bleeding complications depending on their mechanism.
Regular monitoring helps detect and manage side effects early.
Targeted Therapy vs Chemotherapy
Chemotherapy works by killing rapidly dividing cells, affecting both cancer and healthy cells. This usually leads to side effects such as hair loss and nausea.
Targeted therapy, on the other hand, focuses on specific molecular abnormalities, which may result in a different side effect profile.
However, targeted therapy does not replace chemotherapy in all cases. Sometimes both treatments are used together.
The Role of Molecular Testing in Precision Oncology
Molecular testing is essential before starting targeted therapy.
Testing identifies:
- Gene mutations
- Protein overexpression
- Tumor-specific markers
This helps determine whether a patient will benefit from a specific targeted drug.
Precision oncology ensures that treatment is aligned with the unique biology of the tumor.
Frequently Asked Questions
How is targeted therapy different from chemotherapy?
Targeted therapy focuses on specific genetic mutations or proteins that promote cancer growth, while chemotherapy affects rapidly dividing cells more broadly. This precision approach may reduce certain side effects, but still requires careful medical supervision.
Is targeted therapy a cure for cancer?
Targeted therapy can significantly slow or control cancer growth in some patients. However, it is not always curative. Outcomes depend on cancer type, stage, mutation profile, and individual response to treatment.
How long does targeted therapy treatment last?
Treatment duration varies depending on cancer type and response. Some patients take targeted therapy for months or years as long as the cancer responds and side effects remain manageable.
Are there serious risks with targeted therapy?
Although generally well tolerated, targeted therapy can cause serious side effects, such as heart problems, liver toxicity, or high blood pressure. Regular monitoring and follow-up help reduce risks and manage complications early.
Can targeted therapy be combined with other treatments?
Yes, targeted therapy is commonly combined with chemotherapy, immunotherapy, or radiation therapy to enhance effectiveness. The treatment plan depends on tumor biology and the patient’s overall health condition.
Conclusion
Targeted therapy represents a major advancement in cancer treatment by focusing on specific molecular changes within cancer cells. Through biomarker testing and precision medicine approaches, this treatment allows for more individualized care.
While not suitable for every patient, targeted therapy offers promising results for many types of cancer. Consultation with an oncology specialist and comprehensive molecular testing are essential steps in determining eligibility and optimizing outcomes in precision cancer treatment.
